https://www.selleckchem.com/pr....oducts/4-phenylbutyr
f chronic disease were identified. Although none was specific to the CKD population, features could be adapted and tested to address the complex, acute care needs of patients with CKD.The management of pain in patients with chronic kidney disease (CKD) is challenging for many reasons. These patients have an increased susceptibility to adverse drug effects due to altered drug metabolism and excretion, and there are limited safety data for use in this population despite a high pain burden. Non-steroidal anti-inflammato
Like
Comment
Share